CML Diabetes - 2009 - Glycemic variability correlates strongly with postprandial β-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents.


Quantitative EEG in type 1 diabetic adults with childhood exposure to severe hypoglycaemia: a 16 year follow-up study. - February, 2012
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled Diabetic Retinopathy Candesartan Trials. - January, 2012
Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. - December, 2011
Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. - November, 2011
Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients. - October, 2011
Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. - September, 2011
Vibration perception threshold as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes: results from the DCCT/EDIC study. - August, 2011
Rosiglitazone and cognitive stability in older individuals with type 2 diabetes and mild cognitive impairment. - July, 2011
Acute pancreatitis in type 2 diabetes treated with exenatide or sitagliptin: a retrospective observational pharmacy claims analysis. - June, 2011
Predictors of responders to insulin therapy at 1 year among adults with type 2 diabetes. - May, 2011
Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities. - April, 2011
Thiazolidinediones and fractures: evidence from translating research into action for diabetes - March, 2011
A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects - February, 2011
Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomized trial - January, 2011
Effects of medical therapies on retinopathy progression in type 2 diabetes. - December, 2010
PYY3–36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. - November, 2010
The shape of the metabolic memory of HbA1c: re-analysing the DCCT with respect to time-dependent effects. - October, 2010
An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. - September, 2010
Correlations of fasting and postprandial blood glucose increments to the overall diurnal hyperglycaemic status in type 2 diabetic patients: variations with levels of HbA1c. - August, 2010
Proteomics reveals novel oxidative and glycolytic mechanisms in type 1 diabetic patients’ skin which are normalized by kidney–pancreas transplantation. - July, 2010
Effect of rosiglitazone and ramipril on β-cell function in people with impaired glucose tolerance or impaired fasting glucose: The DREAM trial. - June, 2010
The gait and balance of patients with diabetes can be improved: a randomised controlled trial. - May, 2010
Efficacy of leptin therapy in the different forms of human lipodystrophy. - April, 2010
Long-term glycaemic control with metformin–sulphonylurea–pioglitazone triple therapy in PROactive (PROactive 17). - March, 2010
Efficacy of a continuous GLP-1 infusion compared with a structured insulin infusion protocol to reach normoglycemia in nonfasted type 2 diabetic patients: a clinical pilot trial. - February, 2010
Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes study. - January, 2010
Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal–jejunal exclusion. - December, 2009
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). - November, 2009
Glycemic variability correlates strongly with postprandial β-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents. - October, 2009
Type 2 diabetes risk alleles are associated with reduced size at birth. - September, 2009
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. - August, 2009
Amplified hormonal counterregulatory responses to hypoglycemia in rats after systemic delivery of a SUR-1-selective K+ channel opener? - July, 2009
Risk of coronary artery disease associated with initial sulphonylurea treatment of patients with type 2 diabetes: a matched case–control study. - June, 2009
The impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women in two randomized, placebo-controlled clinical trials. - May, 2009
Effects of a controlled hypoglycaemia test on QTc in adolescents with type 1 diabetes. - April, 2009
Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone. - March, 2009
10-year follow-up of intensive glucose control in type 2 diabetes. - February, 2009
Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus. - January, 2009

© Remedica 2012. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without the prior permission of the copyright owners. While every effort is made by the publishers and editorial board to see that no inaccurate or misleading data, opinions, or statements appear in this journal, they wish to make it clear that the material contained in the publication represents a summary of the independent evaluations and opinions of the authors and contributors. As a consequence, the board, publishers, and any supporting company accept no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content of the publication or the use of any drug or device in a way that lies outside its current licensed application in any territory. For detailed information on any drugs or devices discussed in this publication, readers are advised to consult the manufacturer’s prescribing information.

Produced and published by Remedica Medical Education and Publishing Limited.

February 08, 2012

CLOSE

To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader.

Produced and published by Remedica Medical Education and Publishing Limited.

» Contact us

CML Diabetes

» Advanced search

Paper of the Month - October, 2009

Glycemic variability correlates strongly with postprandial β-cell dysfunction in a segment of type 2 diabetic patients using oral hypoglycemic agents.

Kohnert KD, Augstein P, Zander E et al.

View Archive »

WEB LINKS

Post Page On

SUBMIT AN ARTICLE


0 rating

February 08, 2012 CLOSE To subscribe to updates from this journal click Confirm. Updates will be displayed in your default RSS reader. Produced and published by Remedica Medical Education and Publishing Limited. » Contact us

CML Diabetes » Advanced search